These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34413148)

  • 41. Cost-effectiveness of gilteritinib for relapsed/refractory
    Pandya BJ; Qi CZ; Garnham A; Yang H; Shah MV; Zeidan AM
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1469-1481. PubMed ID: 34595955
    [No Abstract]   [Full Text] [Related]  

  • 42. Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease.
    Guadagnolo BA; Punglia RS; Kuntz KM; Mauch PM; Ng AK
    J Clin Oncol; 2006 Sep; 24(25):4116-22. PubMed ID: 16943528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cost-effectiveness analysis of maintenance therapy with rituximab in patients with follicular lymphoma responding to induction therapy at the first line].
    Castro Gómez AJ; López-Guillermo A; Rueda Domínguez A; Salar A; Varela Moreno C; Rubio-Terrés C
    Rev Esp Salud Publica; 2012; 86(2):163-76. PubMed ID: 22991059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic management strategies for adults and children with minor head injury: a systematic review and an economic evaluation.
    Pandor A; Goodacre S; Harnan S; Holmes M; Pickering A; Fitzgerald P; Rees A; Stevenson M
    Health Technol Assess; 2011 Aug; 15(27):1-202. PubMed ID: 21806873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.
    Clarke A; Pulikottil-Jacob R; Grove A; Freeman K; Mistry H; Tsertsvadze A; Connock M; Court R; Kandala NB; Costa M; Suri G; Metcalfe D; Crowther M; Morrow S; Johnson S; Sutcliffe P
    Health Technol Assess; 2015 Jan; 19(10):1-668, vii-viii. PubMed ID: 25634033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of lenalidomide plus rituximab versus rituximab monotherapy in patients with previously treated follicular lymphoma: a societal view.
    Thielen FW; Kersten MJ; Kuizenga P; Hoogendoorn M; Posthuma EF; Stevens WB; A Uyl-de Groot C; Blommestein HM
    Expert Rev Anticancer Ther; 2021 Dec; 21(12):1411-1422. PubMed ID: 34428992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography.
    Klose T; Leidl R; Buchmann I; Brambs HJ; Reske SN
    Eur J Nucl Med; 2000 Oct; 27(10):1457-64. PubMed ID: 11083533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Informativeness of whole-body diffusion-weighted magnetic resonance imaging and positron emission tomography with computed tomography in follicular lymphoma].
    Nesterova ES; Yatsyk GA; Lutsik NS; Kravchenko SK; Sudarikov AB; Krasil'nikova IV; Gemdzhian EG; Kovrigina AM
    Ter Arkh; 2020 Sep; 92(7):55-62. PubMed ID: 33346445
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-Effectiveness of Self-Expandable Transcatheter Aortic Valves in Intermediate-Risk Patients.
    Tam DY; Hughes A; Wijeysundera HC; Fremes SE
    Ann Thorac Surg; 2018 Sep; 106(3):676-683. PubMed ID: 29730344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different Imaging Strategies in Patients With Possible Basilar Artery Occlusion: Cost-Effectiveness Analysis.
    Beyer SE; Hunink MG; Schöberl F; von Baumgarten L; Petersen SE; Dichgans M; Janssen H; Ertl-Wagner B; Reiser MF; Sommer WH
    Stroke; 2015 Jul; 46(7):1840-9. PubMed ID: 26022634
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost effectiveness of moderate to severe psoriasis therapy with etanercept and ustekinumab in the United States.
    Villacorta R; Hay JW; Messali A
    Pharmacoeconomics; 2013 Sep; 31(9):823-39. PubMed ID: 23975739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cost-effectiveness of para-aortic lymphadenectomy before chemoradiotherapy in locally advanced cervical cancer.
    Lee JY; Kim Y; Lee TJ; Jeon YW; Kim K; Chung HH; Kim HJ; Park SM; Kim JW
    J Gynecol Oncol; 2015 Jul; 26(3):171-8. PubMed ID: 25925292
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.
    Cooper KL; Meng Y; Harnan S; Ward SE; Fitzgerald P; Papaioannou D; Wyld L; Ingram C; Wilkinson ID; Lorenz E
    Health Technol Assess; 2011 Jan; 15(4):iii-iv, 1-134. PubMed ID: 21276372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer.
    Schreyögg J; Weller J; Stargardt T; Herrmann K; Bluemel C; Dechow T; Glatting G; Krause BJ; Mottaghy F; Reske SN; Buck AK
    J Nucl Med; 2010 Nov; 51(11):1668-75. PubMed ID: 21051648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer.
    Acevedo JR; Fero KE; Wilson B; Sacco AG; Mell LK; Coffey CS; Murphy JD
    J Clin Oncol; 2016 Nov; 34(32):3886-3891. PubMed ID: 27551113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-Effectiveness of Obinutuzumab in Combination with Bendamustine Followed by Obinutuzumab Maintenance versus Bendamustine Alone in Treatment of Patients with Rituximab-Refractory Follicular Lymphoma in Norway.
    Haukaas FS; Ohna A; Krivasi T
    Appl Health Econ Health Policy; 2018 Aug; 16(4):569-577. PubMed ID: 29923173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suspected carotid artery stenosis: cost-effectiveness of CT angiography in work-up of patients with recent TIA or minor ischemic stroke.
    Tholen AT; de Monyé C; Genders TS; Buskens E; Dippel DW; van der Lugt A; Hunink MG
    Radiology; 2010 Aug; 256(2):585-97. PubMed ID: 20656842
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-Effectiveness Analysis of
    Froelich MF; Schnitzer ML; Holzgreve A; Gassert FG; Gresser E; Overhoff D; Schwarze V; Fabritius MP; Nörenberg D; von Münchhausen N; Hokamp NG; Auernhammer CJ; Ilhan H; Todica A; Rübenthaler J
    Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33670457
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.
    Mozaffarian D; Liu J; Sy S; Huang Y; Rehm C; Lee Y; Wilde P; Abrahams-Gessel S; de Souza Veiga Jardim T; Gaziano T; Micha R
    PLoS Med; 2018 Oct; 15(10):e1002661. PubMed ID: 30278053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Follow-Up 18F-FDG PET/CT versus Contrast-Enhanced CT after Ablation of Liver Metastases of Colorectal Carcinoma-A Cost-Effectiveness Analysis.
    Schnitzer ML; Froelich MF; Gassert FG; Huber T; Gresser E; Schwarze V; Nörenberg D; Todica A; Rübenthaler J
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32867107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.